Eva Kempers &
Marieke J.H.A. Kruip/LinkedIn
Aug 17, 2025, 08:21
Eva Kempers: Menstrual Blood Loss and Quality of Life in Antiplatelet Therapy
Research and Practice in Thrombosis and Haemostasis (RPTH) shared a study by Eva Kempers, Postdoctoral researcher at the University of Antwerp, on LinkedIn :
“This study from Eva Kempers and team examined menstrual blood loss and related quality of life among women on antiplatelet therapy and a control group.
Their data reveal that both outcomes were comparable, great news for women who need antiplatelet therapy.”
Read the full article here.
Article: Menstrual bleeding-specific quality of life in women on antiplatelet therapy
Authors: Eva K. Kempers, Johanna A. van der Zande, Paula M. Janssen, Jérôme M.J. Cornette, Jolien W. Roos–Hesselink
Senior author: Marieke J.H.A. Kruip

Find the newest developments in clotting science in Hemostasis Today.
Antiplatelet Therapy
Eva Kempers
Health
Hematology
Hemostasis Today
Jérôme M.J. Cornette
Johanna A. van der Zande
Jolien W. Roos–Hesselink
Marieke J.H.A. Kruip
Medicine
menstrual bleeding
menstrual blood loss
Paula M. Janssen
Research and Practice in Thrombosis and Haemostasis
RPTH Journal
University of Antwerp
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS